Journal
Journal of Hematology & Oncology
Publication Date
12-16-2023
Volume
16
Issue
1
First Page
122
Document Type
Open Access Publication
DOI
10.1186/s13045-023-01520-7
Rights and Permissions
Vose, J.M., Fu, K., Wang, L. et al. Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium. J Hematol Oncol 16, 122 (2023). https://doi.org/10.1186/s13045-023-01520-7 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Recommended Citation
Vose, Julie M; Kahl, Brad S; and et al., "Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: A report from The North American Mantle Cell Lymphoma Consortium." Journal of Hematology & Oncology. 16, 1. 122 (2023).
https://digitalcommons.wustl.edu/oa_4/3715
Additional Links
Supplemental material is available for this article at publisher site.
